|
Real-time Estimate
Cboe Europe
05:50:42 19/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.688 CHF | 0.00% |
|
0.00% | - |
| 02:20pm | DocMorris AG : UBS remains Neutral | ZD |
| 12:52pm | DocMorris AG : Jefferies gives a Buy rating | ZD |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 486.2 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 68.14% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 686.3 | 722.2 | 707.2 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 60.81% | 5.23% | -2.08% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -6.14x | -12.3x | -34.5x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.48x | 1.49x | 1.64x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x | 0.5x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.39x | 0.35x | 0.33x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.55x | 0.52x | 0.48x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -40.4x | 34.1x | 13.7x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -10.6x | -23.5x | -219x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -9.63x | -22.5x | -46x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -10.4% | -4.44% | -2.17% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.567 | -0.7828 | -0.2795 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,237 | 1,389 | 1,485 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -17 | 21.18 | 51.6 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -64.79 | -30.71 | -3.225 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -81.01 | -43.68 | -22.4 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 200.1 | 236 | 221 |
| Reference price 2 | 235.500 | 25.560 | 73.750 | 19.980 | 5.950 | 9.630 | 9.630 | 9.630 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 50,489 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.64x | 0.74x | 11x | -.--% | 1.57TCr | |
| 21.75x | 0.84x | 14.18x | 1.03% | 670.78Cr | |
| 16.11x | 0.73x | 7.62x | 2.31% | 612.94Cr | |
| 14.99x | 0.98x | 7.09x | 2.82% | 431.48Cr | |
| 14.46x | 1.24x | 7.59x | 5.56% | 321.84Cr | |
| 13.74x | 0.56x | 4.49x | 5.03% | 302.46Cr | |
| 14.43x | 0.87x | 6.54x | 4.44% | 301.28Cr | |
| 31.19x | - | - | - | 242.47Cr | |
| Average | 18.04x | 0.85x | 8.36x | 3.03% | 556.09Cr | |
| Weighted average by Cap. | 17.82x | 0.81x | 9.56x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
